Prediction Case File
YouTubeTracking Live

Friends! In this video, I will discuss 2 high conviction stocks in my portfolio.

2 extracted signals · 0 resolved · 2 still active

The Patient Investor profile imageThe Patient InvestorIndependent analyst profile
Source published
05 Sept 2025, 22:44 UTC
Recorded by Tahlil Plus
18 May 2026, 20:23 UTC
Video preview for Friends! In this video, I will discuss 2 high conviction stocks in my portfolio.
Source overview

AI-generated source summary

The analyst discusses two stocks he intends to hold long-term. The first is Constellation Energy (CEG), currently priced at $309.06, down 13% in the last month, he calculates a target price of $582.2, saying that this stock is undervalued due to power needed from data centers. The second stock discussed is Mama's Creations, ticker MAMA, a food company whose gross margins are up from 11.9% to 27.0%. Citing a CEO with a profitability focus who just acquired Crown 1 Enterprises for 0.3x revenue. This acquisition has increased sales to 40% and based on the CEO's goal of 1 billion by 2030 and given the debt decrease this leads to a target of approximately $53.71 if they sustained their earnings and reach their goals.

AI-generated summary based on the source content.

Live evaluation

Signal outcomes at a glance

Tracking Live
Signals
2
Extracted from this source
Open
2
Still being tracked
Successful
0
Resolved successfully
Failed
0
Resolved unsuccessfully
Other
0
Cancelled, invalid or excluded
Resolved success
0 resolved; open signals omitted
Extracted intelligence

Signals in this source

Case timeline

Evidence and evaluation progress

  1. Original source published

    The analyst published the original source item.

  2. Source recorded by Tahlil Plus

    The public source was preserved as the evidence record for this case.

  3. Market predictions extracted

    2 eligible signals linked to this case.

  4. Outcome tracking started

    Tahlil Plus began monitoring the extracted predictions.

  5. Live evaluation in progress

    2 signals remain active.

Analyst snapshot

The Patient Investor

Platform-wide history, separate from this source evaluation.

Reliability
47.3
Tracked signals
326
Historical success
34.1%
View full analyst profile →
Methodology & disclosure

Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.

Continue the evidence trail